Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial


LIMERICK, Ireland–(BUSINESS WIRE)–This week, Cook Medical made patient-level data from the Zilver® PTX® randomised control trial (RCT) available by request on Cook provides this data to encourage further collaboration with researchers to benefit patients with peripheral arterial disease. “We will continue to support our customers and their patients by sharing what we’ve discovered from our research and data in the area of paclitaxel,” said Mark Breedlove, vice president of Co

- Advertisement -